Text Size
S
M
L
Listen
Santen Global
menu
Patients
Healthcare Professionals
Careers
Investors
Listen
Tap on the left to use.
Who We Are
Message
Message from the CEO
Corporate Story
Corporate Story
CORE PRINCIPLE / Our Commitment
CORE PRINCIPLE / Our Commitment
Our Values
Our Values
History
History of Santen
Corporate Executives
Corporate Executives
Corporate Governance
Corporate Governance
Policies
Policies and Statements
Company Infomation
Overview / Map
Global Operation
What We Do
MTP & Santen 2030
Medium-term Management Plan
Santen 2030
Efforts to Enhance Patients' Satisfaction
Efforts to Enhance Product Safety
Efforts to Enhance Product Usability
Efforts to Address Untreated Patients
Research & Development
Research & Development
The Ophthalmic Product Process: R&D
Clinical Trial Information
Partnering
Santen's Partnership
Our Partners
Partnering Contact
Production
Production
Safety and Quality Assurance
The Ophthalmic Production Process: Production
Sales & Marketing
Sales & Marketing
Our Stories
Sustainability
Sustainability
Our Sustainability Commitment
Sustainability at Santen
Social
Access to Healthcare
Research & Development in Ophthalmology
Product Quality & Safety
Supply Chain
Human Rights
Talent
Digital Transformation (DX)
Governance
Corporate Governance
Compliance
Ethical Marketing
Risk Management
Information Security
Environment
Environmental initiatives
Measures against Climate Change
Environmental Load Reduction
Biodiversity
Disclosures Based on the TCFD Recommendations
Inclusion
Inclusive Society Santen Promotes
Inclusion Starting from Blind Football
Together with Society
With Employees
Related Information
Participating in the UN Global Compact
Social Contribution Activities
Stakeholder Engagement
Environment Data (up-to-date)
Social Data (up-to-date)
Governance Data (up-to-date)
GRI Standards Content Index
Sustainability Library
External Assessment
News
News
Show All
Press Release
IR News
Information
HOME
News
2013
2013 News
Press Release
IR News
Information
Press Release
12.09.2013
Santen Launches Sante ALn, an OTC Eye Drop, and Redesign Packaging for Sante AL Cool II and Sante ALFree New Eye Drop
12.09.2013
Notice on the Establishment of Subsidiary in Singapore
12.09.2013
Santen Launches Sante PC (Pouch Type), an OTC Eye Drop in Limited Quantities on December 9, 2013
12.06.2013
European marketing authorization application for Ikervis has been filed to the EMA for the treatment of Dry Eye Disease
11.29.2013
Santen to Support People in the Philippines Affected by Typhoon Haiyan through Donations
Press Release
IR News
12.09.2013
Notice on the Establishment of Subsidiary in Singapore
12.06.2013
European marketing authorization application for Ikervis has been filed to the EMA for the treatment of Dry Eye Disease
11.29.2013
Santen to Support People in the Philippines Affected by Typhoon Haiyan through Donations
11.25.2013
Santen Launches Alesion® 0.05% Ophthalmic Solution for Allergic Conjunctivitis Treatment in Japan
11.22.2013
Intravitreal VEGF Inhibitor "EYLEA" Obtains Additional Indication of Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO)
IR News
Information
10.09.2013
Santen to release Annual Report 2013
07.29.2013
Santen to launch its New Group Website
06.03.2013
Notice of the Relocation of Head Office
Information
News Archive
